N+1 Singer restated their corporate rating on shares of CVS Group Plc (LON:CVSG) in a research note published on Thursday.

A number of other analysts have also issued reports on the company. Berenberg Bank upped their target price on CVS Group Plc from GBX 910 ($11.37) to GBX 1,000 ($12.49) and gave the stock a buy rating in a research note on Thursday, October 20th. Peel Hunt lowered CVS Group Plc to an add rating and upped their target price for the stock from GBX 950 ($11.87) to GBX 1,000 ($12.49) in a research note on Friday, September 23rd. Finally, Investec restated a buy rating and issued a GBX 880 ($10.99) target price on shares of CVS Group Plc in a research note on Tuesday, August 2nd.

CVS Group Plc (LON:CVSG) opened at 1037.00 on Thursday. The company has a 50 day moving average price of GBX 873.16 and a 200-day moving average price of GBX 837.71. The firm’s market capitalization is GBX 622.18 million. CVS Group Plc has a 1-year low of GBX 645.00 and a 1-year high of GBX 1,038.00.

The company also recently disclosed a dividend, which will be paid on Friday, December 9th. Stockholders of record on Thursday, November 24th will be given a dividend of GBX 3.50 ($0.04) per share. The ex-dividend date of this dividend is Thursday, November 24th. This is a positive change from CVS Group Plc’s previous dividend of $3.00. This represents a dividend yield of 0.37%.

In other news, insider Richard A. Connell acquired 2,109 shares of CVS Group Plc stock in a transaction dated Friday, October 28th. The shares were purchased at an average cost of GBX 878 ($10.97) per share, for a total transaction of £18,517.02 ($23,134.71). Also, insider Mike McCollum acquired 3,049 shares of CVS Group Plc stock in a transaction dated Friday, October 21st. The shares were purchased at an average price of GBX 862 ($10.77) per share, for a total transaction of £26,282.38 ($32,836.56).

WARNING: This piece was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another publication, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The legal version of this piece can be read at https://www.thecerbatgem.com/2016/11/25/cvs-group-plcs-cvsg-corporate-rating-reaffirmed-at-n1-singer.html.

CVS Group Plc Company Profile

CVS Group plc is a holding company. The principal activities of the Company are to operate animal veterinary practices, veterinary diagnostic businesses, pet crematoria and an online pharmacy and retail business. Its segments are Veterinary Practice, Laboratories, Pet Crematoria and Animed Direct. The Veterinary Practice segment offers treatment for companion animals, equine and farm animals.

Receive News & Stock Ratings for CVS Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group Plc and related stocks with our FREE daily email newsletter.